SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-23-282769
Filing Date
2023-11-24
Accepted
2023-11-24 16:33:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d590301dsc13g.htm SC 13G 38708
  Complete submission text file 0001193125-23-282769.txt   40241
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94231 | Film No.: 231436998
SIC: 2836 Biological Products, (No Diagnostic Substances)